CDKN2A and prostate carcinoma: In prostate cancer, inhibiton of Cytohesin 1 by siRNA, reduces the pro-tumorigenic role of Insulin Growth Factor Receptor (IGFR) signaling (Weizhong et al., 2011), suggesting that this ARF GEF could be targeted to impair prostate cancer progression.